GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver

Clinical trial NCT04546022 · COMPLETED

Trial details

NCT number: NCT04546022
Sponsor: National Defense Medical Center, Taiwan
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Galactose Single Point (GSP), Residual Liver Function

Start date: 2007-07-05
Primary completion: 2007-08-12
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.